Italy
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.03%
|
Dec. 31, 2023 | USD 2.00 | 0.87% |
|
Italy |
|
2 |
29.93%
|
Dec. 31, 2023 | USD 7.70 | 1.61% |
|
Italy |
|
3 |
23.58%
|
Dec. 31, 2023 | USD 61.94 | 0.17% |
|
Italy |
|
4 |
17.52%
|
Dec. 31, 2023 | USD 106.08 | -0.85% |
|
Italy |
|
5 |
14.16%
|
Dec. 31, 2023 | USD 40.50 | -2.05% |
|
Italy |
|
6 |
-26.72%
|
Dec. 31, 2023 | USD 19.11 | -0.17% |
|
Italy |
|
7 |
-178.87%
|
Dec. 31, 2023 | USD 10.99 | 1.17% |
|
Italy |
The Biotechnology company in Italy with the highest EBT Margin is Arterra Bioscience (Milan Stock Exchange: ARBS.MI) at 39.03%.
The Biotechnology company in Italy with the lowest EBT Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -178.87%.
The top 10 Biotechnology companies in Italy by EBT Margin are Arterra Bioscience, Franchetti S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., SOL S.p.A., Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Biotechnology companies in Italy by EBT Margin are Newron Pharmaceuticals S.p.A., Philogen S.p.A., SOL S.p.A., DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., Franchetti S.p.A. and Arterra Bioscience.